A new study suggests smoking during pregnancy may leave offspring more vulnerable to metabolic disease later in life, especially if they also adopt a poor diet as adults. Researchers used a mouse ...

The researchers estimate that being above or below your usual level of mental sharpness can shift productivity by about 30 to 40 minutes in a single day. Across the gap between your best and worst ...

Burping, nausea and vomiting are all recognised side effects of GLP-1 drugs, and any of those could make breath smell worse ...

Diabetes UK has over 170,000 members, and constantly works with diabetics, their families and friends, and healthcare professionals, to improve UK diabetes care. Diabetes UK also carries the torch for ...

Semaglutide is a relatively new drug that has been shown to be just as effective at reducing body weight as certain weight loss surgeries. The drug’s effects were uncovered during a clinical trial led ...

A large study found that higher daily step counts were linked to lower risks of death and cardiovascular disease, even in people who were highly sedentary. The biggest benefit was seen around 9,000 to ...

A new review suggests people taking GLP-1 weight loss drugs can lose a meaningful amount of muscle as well as fat. That may help explain the hollowed look sometimes called ‘Ozempic face’, although the ...

A new report says the average number of years people in the UK spend in good health has fallen by about two years over the last decade. The decline has been especially severe in poorer parts of the ...

Researchers found that some people using fitness and calorie tracking apps reported feelings of shame, irritation and ...

A new study suggests the blood vessels inside fat tissue do more than respond to obesity and type 2 diabetes – they may actively help drive the disease process. Researchers found clear changes in ...

An early clinical trial suggests a minimally invasive procedure called duodenal mucosal resurfacing may reduce weight regain after people stop drugs such as semaglutide or tirzepatide. Patients who ...

A major clinical trial has found that continuous glucose monitoring can improve blood sugar control in adults with type 2 diabetes treated with basal insulin. The study compared real-time CGM with ...